跳至主要内容
临床试验/NCT01372007
NCT01372007已完成3 期

Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2011年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
24
试验地点
1
主要终点
% reduction in drain fluid volume over a period of 5 days post study treatment administration in both arms.

研究概览

简要总结

Total mesorectal excision (TME) is a precise dissection of the rectum and all para-rectal lymph nodes within the mesorectal envelope. It is becoming universally recognized and accepted as the standard technique for surgical excision of rectum carcinomas. TME results in lowest rates of local recurrence, especially when combined with pre-operative chemo-radiotherapy.

Especially after pre-operative chemo-radiotherapy, the post-operative drainage may be important. The quick decrease of this drainage will enable the early mobilisation of the patient and may shorten the time of hospitalization. If this decrease in fluid production can be achieved, it will have a positive effect on the Quality of Life of the patient and will ensure health economic savings by reduction of hospitalization time and resources.

Somatostatin analogues have shown to be able to decrease the secretion of numerous types of bodily fluids.

The aim of this study is to investigate if lanreotide Autogel 120mg is capable to reduce the fluid discharge in patients that underwent a TME for rectumcarcinoma.

Lanreotide Autogel 120mg compared to placebo, administered post-surgery on the fluid discharge in the drain of the patient that underwent a total mesorectum excision (TME) for rectal carcinoma. Patient planned to have a TME will be asked to participate in the study. When they have provided written informed consent, they will be randomized 1:1 to receive either placebo or lanreotide autogel 120mg. Drain fluid will be checked for hematocrit daily post-surgery. Once hematocrit levels of the drain fluid are <10%, study medication or placebo will be administered. After administration the volume of the drain fluid will be measured every 12 hours for at least 5 days. A sample of the drain fluid will be collected every 24 hours for at least 5 days and frozen at -70°C for total protein content, sodium and chloride analysis afterwards. If the patient has a hematocrit >10% in his drain fluid for a period of 5 days, this patient can not be randomized.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male and female patients
  • 18-75 years
  • written informed consent to participate the study
  • scheduled to have a total mesorectal excision (TME) for rectumcarcinoma

排除标准

  • patients with a known intolerance for somatostatin analogues, lanreotide or any of it's excipients
  • patients younger than 18 years
  • patients unable to provide written informed consent
  • patients who received somatostatin or any of it's analogues the last 30 days before the start of the study
  • Pregnant and breast-feeding women
  • Women not using contraception

研究组 & 干预措施

Lanreotide Autogel 120mg

Experimental

干预措施: Lanreotide Autogel 120mg (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

% reduction in drain fluid volume over a period of 5 days post study treatment administration in both arms.

时间窗: Drain fluid will be checked every day with a minimum of 5 days or until the drain is removed.

Drain fluid will be checked for hematocrit daily post-surgery. Once hematocrit levels of the drain fluid are \<10%, study medication or placebo will be administered. After administration the volume of the drain fluid will be measured every 12 hours for at least 5 days. A sample of the drain fluid will be collected every 24 hours for at least 5 days and frozen at -70°C for total protein content, sodium and chloride analysis afterwards.

次要结局

  • Evaluation of the Quality of life of the patient.(This will be evaluated during a hospitalization of approximately 10 days.)
  • Evaluation of the time of mobilisation after surgery.(This will be evaluated during a hospitalization of approximately 10 days.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Influence of Somatuline Autogel 120mg on... | 临床试验